There are currently over 20 marketed products using peptides protected under the patent including such cosmeceutical brands as Fusion Beauty, Smashbox, Isomers, and B Kamins. Numerous additional product roll outs are planned in 2008.
Stephen Beatty, president and CEO of Helix, said: “While our primary focus is dermatological therapeutic development, this represents our first issued patent specifically targeting cosmetic and skin care applications, which is the direct result of our efforts to diversify our sequences as well as their bioactivities and application.”